| Filed On | Filing |
|---|---|
| 14 Aug 2025 | SCHEDULE 13G/A |
| 09 Jun 2025 | 15-12G |
| 04 Jun 2025 | EFFECT |
| 04 Jun 2025 | EFFECT |
| 04 Jun 2025 | EFFECT |
| 04 Jun 2025 | EFFECT |
| 04 Jun 2025 | EFFECT |
| 04 Jun 2025 | EFFECT |
| 03 Jun 2025 | SCHEDULE 13D/A |
| 03 Jun 2025 |
Form 4: Fortress Biotech, Inc., 10% owner
Sold 100,000 shares ($129K) · Returned 6,122,249 shares to the issuer ($25.1M) · Disposed of 700,000 CLASS A COMMON STOCK, PAR VALUE $0.0001 (Disposition to Issuer) |
| 30 May 2025 | 25-NSE |
| 30 May 2025 |
Form 4: Weiss Michael S, Director
Received 12,195 shares as a grant or award · Received 50,000 shares as a grant or award ($64.5K) · Disposed of 187,007 shares (Tender Offer) |
| 30 May 2025 |
Form 4: Salzman Barry M, Director
Received 12,195 shares as a grant or award · Disposed of 147,007 shares (Tender Offer) |
| 30 May 2025 |
Form 4: Rosenwald Lindsay A Md, Director
Received 12,195 shares as a grant or award · Received 50,000 shares as a grant or award ($64.5K) · Disposed of 207,007 shares (Tender Offer) |
| 30 May 2025 |
Form 4: Oliviero James F Iii, Director
Disposed of 3,759,929 shares (Tender Offer) |
| 30 May 2025 |
Form 4: Herskowitz Neil, Director
Received 12,195 shares as a grant or award · Disposed of 147,007 shares (Tender Offer) |
| 30 May 2025 |
Form 4: Gray William Garrett, Chief Financial Officer
Disposed of 1,446,322 shares (Tender Offer) |
| 30 May 2025 |
Form 4: Bechon Christian, Director
Received 12,195 shares as a grant or award · Disposed of 141,718 shares (Tender Offer) |
| 30 May 2025 |
Form 4: Amit Sharma, Director
Received 12,195 shares as a grant or award · Disposed of 94,246 shares (Tender Offer) |
| 30 May 2025 | S-8 POS |
Loading...
